Find new businesses and brands
Trademark Search > Trademark Category > Pharmaceutical Products > NEUROVANCE PHARMACEUTICALS INC.
NEUROVANCE PHARMACEUTICALS INC.
By: Orexigen Therapeutics, Inc. tweet it Tweet Logo Share on Facebook
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
PRINTED INSTRUCTIONAL, EDUCATIONAL AND TEACHING MATERIALS IN THE FIELD OF TREATMENT AND MANAGEMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
PROVIDING MEDICAL INFORMATION IN THE FIELD OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
This is a brand page for the NEUROVANCE PHARMACEUTICALS INC. trademark by Orexigen Therapeutics, Inc. in La Jolla, CA, 92037. Write a review about a product or service associated with this NEUROVANCE PHARMACEUTICALS INC. trademark. Or, contact the owner Orexigen Therapeutics, Inc. of the NEUROVANCE PHARMACEUTICALS INC. trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the NEUROVANCE PHARMACEUTICALS INC. trademark.
On Tuesday, May 09, 2006, a U.S. federal trademark registration was filed for NEUROVANCE PHARMACEUTICALS INC. by Orexigen Therapeutics, Inc., La Jolla, CA 92037. The USPTO has given the NEUROVANCE PHARMACEUTICALS INC. trademark serial number of 78879974. The current federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED. The correspondent listed for NEUROVANCE PHARMACEUTICALS INC. is AnneMarie Kaiser of KNOBBE, MARTENS, OLSON & BEAR LLP, 2040 Main Street, 14th Floor, Irvine CA 92614 . The NEUROVANCE PHARMACEUTICALS INC. trademark is filed in the category of Pharmaceutical Products , Paper Goods and Printed Material , Medical, Beauty & Agricultural Services . The description provided to the USPTO for NEUROVANCE PHARMACEUTICALS INC. is PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM.
Word Mark: NEUROVANCE PHARMACEUTICALS INC.
Status/
Status Date:
ABANDONED - NO STATEMENT OF USE FILED
4/6/2009

Serial Number: 78879974
Filing Date: 5/9/2006
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 12/12/2006
Last Applicant/Owner: Orexigen Therapeutics, Inc.
La Jolla, CA 92037
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (PHARMACEUTICALS INC.)
Correspondent:
KNOBBE, MARTENS, OLSON & BEAR LLP
2040 Main Street, 14th Floor
Irvine CA 92614
Classification Information
International Class Code(s): 005
US Class Code(s): 006, 018, 044, 046, 051, 052
Primary Class: Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Class(es) Status: Active
First Use Anywhere: NOT PROVIDED
First Use In Commerce: NOT PROVIDED
 
International Class Code(s): 016
US Class Code(s): 002, 005, 022, 023, 029, 037, 038, 050
Primary Class: Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
Class(es) Status: Active
First Use Anywhere: NOT PROVIDED
First Use In Commerce: NOT PROVIDED
 
International Class Code(s): 044
US Class Code(s): 100, 101
Primary Class: Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
Class(es) Status: Active
First Use Anywhere: NOT PROVIDED
First Use In Commerce: NOT PROVIDED
 

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the LegalForce/Trademarkia network! You can register your trademark in 100+ countries in the world through LegalForce Network.

LegalForce Network can help you incorporate a business around your NEUROVANCE PHARMACEUTICALS INC. trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>
trademark
100% Satisfaction Guarantee
protect your valuable brand now.
 
How it works?
  1. Legalforce RAPC - #1 U.S. Trademark Filer since 2010.
  2. Describe how your business or product is being used. Register your mark in 100+ countries. Just $159 + govt fees! Start here >>
What our customers say:
I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.
-Camryn, Surrey, UK
Keep Track of this Brand.
Trademark Watch Services
Keep track of how your trademark is being used. Available in the United States and in more than 100 countries. Round-the-clock monitoring. Monthly report on potential infringement.
Trademark Watch Services read more...
Current Trademark Status:
4/6/2009
ABANDONED - NO STATEMENT OF USE FILED
Free Trademark Search:
Search:
Correspondent Search:
AnneMarie Kaiser is a correspondent of NEUROVANCE PHARMACEUTICALS INC. trademark.
Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
 
Available, Get it at $159

This mark may be available for re-registration. You can apply for it through LegalForce Trademarkia at a low cost of $159!

Trademarkia.com will perform a final search in order to verify that this mark is available for re-registration. All Trademarkia services are backed by a 100% satisfaction guarantee.

Canaccord's Adam Cutler Likes Vivus, Orexigen Stocks
Published on:3/23/2012 11:47:32 AM
News Update: Orexigen Soars on High Hopes for Obesity Treatment
Published on:6/28/2010 12:33:27 PM
Orexigen Shares Up 23% On News That Takeda Pharma Agreed to Commercialize Contrave
Published on:9/2/2010 11:38:15 AM
Zagg (ZAGG) Stock - OREX Stock Analysis - Aggressive Growth Stock Picks-Oct. 20, 2010
Published on:10/20/2010 12:29:02 PM
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!